UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000026864
Receipt No. R000030795
Scientific Title A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.
Date of disclosure of the study information 2017/04/05
Last modified on 2019/04/08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.
Acronym A study of platelet derived microparticles in pediatric patients afer hematopoietic stem cell transplantation.
Scientific Title A prospective study of platelet derived microparticles in pediatric patients with coagulopathy afer hematopoietic stem cell transplantation.
Scientific Title:Acronym A study of platelet derived microparticles in pediatric patients afer hematopoietic stem cell transplantation.
Region
Japan

Condition
Condition Pediatirc hematopoietic stem cell tranaplantaion
Classification by specialty
Hematology and clinical oncology Pediatrics
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To identify the significance of PDMP in pediatric patients with coagulopathy after hematopoietic stem sell transplantation, thus leading to early diagnosis and treatment of coagulopathy.
Basic objectives2 Others
Basic objectives -Others Association of cagulopathy and transplant prognosis.
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Evaluation of PDMP : pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months
Key secondary outcomes 1. Evaluation of solulble P-selectin, solulble E-selectin, solulble VCAM-1 and solulble ICAM-1: pre-transplant, post-transplant at week1, week2, week3, week4, 2 months, 3 months
2. Transplant prognosis.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
18 years-old >=
Gender Male and Female
Key inclusion criteria 1. Patients undergoing hematopoietic stem cell transplantation at Hospital of University of the Ryukyus (in- and out-patients) from April 2017 to March 2020.
2. Age of 0-18 years.
Key exclusion criteria 1. Patients having serious coagulopathy such as DIC at transplantation.
2. Patients who refuse to participate in this study.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Nobuyuki
Middle name
Last name Hyakuna
Organization Hospital of University of the Ryukyus
Division name Pediatrics
Zip code 9030215
Address 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan
TEL 098-895-3331
Email hyakunan@med.u-ryukyu.ac.jp

Public contact
Name of contact person
1st name Nobuyuki
Middle name
Last name Hyakuna
Organization Hospital of University of the Ryukyus
Division name Pediatrics
Zip code 9030215
Address 207 Uehara, Nishihara-cho, Okinawa 903-0215, Japan
TEL 098-895-3331
Homepage URL
Email hyakunan@med.u-ryukyu.ac.jp

Sponsor
Institute University of the Ryukyus
Faculty of Medicine
Institute
Department

Funding Source
Organization Life Medicine Research Promotion Foundation
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization University of the Ryukyus
Address Senbaru 1, Nishihara, Okinawa
Tel 098-895-8016
Email knknkyu@to.jim.u-ryukyu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2017 Year 03 Month 15 Day
Date of IRB
2017 Year 03 Month 21 Day
Anticipated trial start date
2017 Year 04 Month 05 Day
Last follow-up date
2020 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Following items will be observed at pre- and post-transplant period.
1. Clinical items: engraftment, GVHD (grade), other complications (infection, DIC, SOS, TMA, graft failure, early death).
2. Laboratory items: PDMP, PAC-1, solulble P-selectin, solulble E-selectin, solulble VCAM-1, solulble ICAM-1

Management information
Registered date
2017 Year 04 Month 05 Day
Last modified on
2019 Year 04 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030795

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.